Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary (2004)
Chapter: Appendix A: Agenda: Learning from SARS: Preparing for the Next Disease Outbreak
Appendix A
Learning from SARS: Preparing for the Next Disease Outbreak
September 30-October 1, 2003
SMITHSONIANS. DILLONRIPLEYCENTERWASHINGTON, DC
AGENDA
TUESDAY, SEPTEMBER 30, 2003
8:30 | Continental Breakfast |
9:00 | Welcome and Opening Remarks Adel Mahmoud, M.D., Ph.D. Chair, Forum on Emerging Infections President, Merck Vaccines |
RECAPPING THE EVENTS: EXPERIENCES FROM THE FIELD
Session I: The Evolution of the Outbreak
Moderator: Harvey Fineberg, President, Institute of Medicine
9:15-9:40 | CHINA: The Epicenter Yi Guan, M.D., Ph.D.,The University of Hong Kong, Queen Mary Hospital |
9:40-10:00 | Discussion |
10:00-10:25 | SARS: Lessons from Toronto Don Low, M.D., FRCPC.,Toronto Medical Laboratories, Mt. Sinai Hospital, Toronto |
10:25-10:45 | Discussion |
10:45-11:10 | WHO: The Global Response David Heymann, M.D.,World Health Organization, Geneva |
11:10-11:30 | Discussion |
11:30 | BREAK |
Session II: Discussion Panel
Moderator: Stanley Lemon, M.D., Vice Chair, Forum on Emerging Infections/Dean of Medicine, The University of Texas Branch at Galveston
11:45 | Discussants: | Reporting Tools and Surveillance Networks: Ann-Marie Kimball, M.D., M.P.H., School of Public Health and Community Medicine, University of Washington International Coordination and Collaboration: Ray Arthur, Ph.D.,National Center for Infectious Diseases, Global Health, CDC (Invited) Animal Coronaviruses—Lessons from SARS: Linda Saif, Ph.D.,Ohio Agricultural Research Center, Ohio State University |
12:30 | Open Discussion |
|
1:00 | Lunch |
|
Session III: The Spectrum of Consequences and Responses
Moderator: James Hughes, M.D., NCID, CDC
2:00-2:25 | Economic Impacts Warwick McKibbin, Ph.D.,Australian National University |
2:25-2:45 | Discussion |
2:45-3:10 | The Implications of SARS Epidemic for China’s Public Health Infrastructure and Political System Yanzhong Huang, Ph.D.,Seton Hall University, Whitehead School of Diplomacy and International Relations, Center for Global Health Studies |
3:10-3:30 | Discussion |
3:30-3:55 | Quarantine and Containment Strategies Marty Cetron, M.D.,National Center for Infectious Diseases, CDC |
3:55-4:15 | Discussion |
4:15-4:40 | Impacts on Health Care Systems G. Neil Thomas, M.D.,Department of Community Medicine, University of Hong Kong (Invited) |
4:40-5:00 | Discussion |
Session IV: Open Discussion
5:00 | Moderator: Joshua Lederberg, Ph.D., Nobel Laureate, Sackler Foundation Scholar, Rockefeller University |
Open Discussion | |
6:00 | Adjournment of the first day |
WEDNESDAY, OCTOBER 1, 2003
8:30 | Continental Breakfast |
9:00 | Opening Remarks/Summary of Day 1 Stanley Lemon, M.D. Vice Chair, Forum on Emerging Infections |
LEARNING FROM OUR LESSONS: THE AGENDA AHEAD
Session V: The Research Agenda and Emerging Technologies
Moderator: Carole Heilman Ph.D., Director, Division of Microbiology and Infectious Diseases, NIAID, NIH
9:15-9:40 | Coronavirus Research Mark Denison, M.D.,Vanderbilt University |
9:40-10:00 | Discussion |
10:00-10:25 | TIGER Technology for Emerging Infectious Disease Surveillance Ranga Sampath, Ph.D.,Ibis Therapeutics, A Division of Isis Pharmaceuticals |
10:25-10:45 | Discussion |
10:45-11:20 | Pharmaceutical Approaches to Antiviral Drug Development Amy Patick, Ph.D. and Peter Dragovich, Ph.D.,Pfizer Inc. |
11:20-11:30 | Discussion |
11:30 | BREAK |
11:45-12:10 | Vaccines: Can We Prevent the Unexpected? Alan Shaw, Ph.D., Merck Research Laboratories |
12:10-12:30 | Discussion |
12:30-12:50 | SARS: Clearing the Air Jerome Schentag, Pharm.D.,State University of New York-Buffalo |
12:50-1:00 | Discussion |
1:00 | LUNCH |
Session VI: Panel Discussion—Preparing for the Next Disease Outbreak
Moderator: Frederick Sparling, M.D., Professor of Medicine, Microbiology, and Immunology, University of North Carolina
2:00 | Discussants: | The Quest to Define and Control SARS: Robert Breiman, M.D., Centre for Health and Population Research, Dhaka, Bangladesh Regulatory Laboratory Planning/Preparedness: Kathryn Carbone, M.D.,Center for Biologics, Food and Drug Administration Future Threats Assessment: Karen Monaghan, NIC,National Intelligence Council Report Public Health Law: Gene Matthews, J.D.,Legal Advisor to CDC Modeling a Response Strategy: Nathaniel Hupert, M.D., M.P.H.,Weill Cornell Medical College Face to Face w/Influenza: Robert Webster, Ph.D.,St. Jude Children’s Research Hospital |
3:30 | Open Discussion | |
5:00 | Closing Remarks/Adjourn | |
